Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26FFG6Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,420
Award facts
- Contract value 100% obligated
- $2,420.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed price delivery order, valued at $2,420.42, is scheduled for completion by November 19, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $1 billion pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of pharmaceuticals, medical supplies, vaccines, and specialty medications to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a prime vendor under DLA's pharmaceutical procurement framework, AmerisourceBergen maintains a track record of competitively awarded contracts with flexible delivery order mechanisms that support ongoing operational medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FFG6Q?
SPE2DR26FFG6Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FFG6Q worth?
The government has obligated $2,420 on SPE2DR26FFG6Q.
Is contract SPE2DR26FFG6Q an order under another contract?
Yes. SPE2DR26FFG6Q is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFG6Q competed?
The extent of competition for SPE2DR26FFG6Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award